30
Participants
Start Date
November 30, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2027
Allergenic Extract
In each subject, a drop of each of the 3 concentrations of the allergenic extract, in addition to the positive control (histamine) and the negative control, will be applied. The application will be duplicated on the subject's anterior forearm, with a distance of approximately 4 cm between each application to avoid overlapping reactions and false-positives results.
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Lead Sponsor
Inmunotek S.L.
INDUSTRY